Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

J. D. de Boer · SciRah

Researcher profile · Semantic Scholar

J. D. de Boer

Share profile

J. D. de Boer — researcher profile on SciRah

h-index: 8
Works: 26
Citations: 171

Most-cited papers

CD47 Expression Defines Efficacy of Rituximab with CHOP in Non–Germinal Center B-cell (Non-GCB) Diffuse Large B-cell Lymphoma Patients (DLBCL), but Not in GCB DLBCL
R. Bouwstra, Yuan He, J. D. de Boer, H. Kooistra +8 more
2019Cancer immunology research37 citations Open access
Semantic Scholar
Population-Based External Validation of the EASIX Scores to Predict CAR T-Cell-Related Toxicities
J. D. de Boer, K. Keijzer, E. Pennings, J. V. van Doesum +10 more
2023Cancers27 citations Open access
Semantic Scholar
The Dutch CAR-T Tumorboard Experience: Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy in The Netherlands
A. Spanjaart, E. Pennings, P. Mutsaers, S. van Dorp +17 more
2023Cancers26 citations Open access
Semantic Scholar
Reducing and controlling metabolic active tumor volume prior to CAR T-cell infusion can improve survival outcomes in patients with large B-cell lymphoma
K. Keijzer, J. D. de Boer, J. V. van Doesum, W. Noordzij +4 more
2024Blood Cancer Journal17 citations Open access
Semantic Scholar
Semi-automated 18F-FDG PET segmentation methods for tumor volume determination in Non-Hodgkin lymphoma patients: a literature review, implementation and multi-threshold evaluation
K. Keijzer, A. Niezink, J. D. de Boer, J. V. van Doesum +3 more
2023Computational and Structural Biotechnology Journal13 citations Open access
Semantic Scholar
Inflammatory reactions mimic residual or recurrent lymphoma on [18F]FDG-PET/CT after CD19-directed CAR T-cell therapy
J. D. de Boer, E. Pennings, A. Kleinjan, J. V. van Doesum +13 more
2023Blood Advances11 citations Open access
Semantic Scholar
Population-based validation of the CAR-HEMATOTOX for hematotoxicity, infections, and survival after CART in R/R LBCL
J. D. de Boer, K. Keijzer, S. van Dorp, P. Mutsaers +19 more
2025Blood Advances10 citations Open access
Semantic Scholar
Site-specific analysis of extranodal involvement in large B-cell lymphoma reveals distinct efficacy with chimeric antigen receptor T-cell therapy
G. Iacoboni, K. Rejeski, Víctor Navarro, T. van Meerten +20 more
2025Leukemia8 citations Open access
Semantic Scholar
High frequency of severe hyperglycemia observed during intensive hematological care: a prospective study using continuous glucose monitoring.
Marieke Tienstra, J. D. de Boer, J. V. van Doesum, K. Keijzer +9 more
2024Endocrine Practice6 citations Open access
Semantic Scholar
Real-World Accuracy of Continuous Glucose Monitoring During Intensive Hematological Care: A Prospective Study
Marieke Tienstra, Riemer A. Been, J. D. de Boer, R. Gans +7 more
2025Diabetes Technology & Therapeutics4 citations Open access
Semantic Scholar
Whole-body CD8+ T-cell PET imaging in patients with large B-cell lymphoma before and during CD19-directed CAR T-cell therapy: a phase 2 study
J. D. de Boer, K. Keijzer, J. V. van Doesum, N. Smit +15 more
2025Nature Communications4 citations Open access
Semantic Scholar
Separation of simultaneously acquired [89Zr]atezolizumab and [18F]FDG PET scans
Zekai Li, J. D. de Boer, T. van Meerten, A. Niezink +4 more
2025European Journal of Nuclear Medicine and Molecular Imaging3 citations Open access
Semantic Scholar
High frequency of hyperglycaemia observed during CAR T‐cell treatment
Marieke Tienstra, J. D. de Boer, J. V. van Doesum, T. van Meerten +1 more
2022Diabetic Medicine3 citations Open access
Semantic Scholar
Site-Specific Analysis of Extranodal Involvement Reveals Distinct Efficacy Outcomes with CAR T-Cell Therapy in Large B-Cell Lymphoma Patients
G. Iacoboni, K. Rejeski, Víctor Navarro Garcés, T. van Meerten +19 more
2024Blood2 citations
Semantic Scholar
Early Recognition of ICANS with a Novel EEG-based DeltaWave Detection System in Patients Receiving CAR T-cell Therapy
Marieke Tienstra, Tatum N. Storck, H. T. van der Galiën, J. D. de Boer +6 more
2025Blood Immunology & Cellular Therapy1 citations Open access
Semantic Scholar
High risk of bleeding following CAR T-cell therapy: Insights from the dutch “Follow that CAR!” registry
Amica Ko, P. Mutsaers, Lukas Van Kleij, F. Leebeek +14 more
2025Blood1 citations
Semantic Scholar
Transformed FL shows improved survival after CAR T-cell therapy compared to de novo LBCL, but early transformation (<12 months) defines a poor-risk subgroup: Results from a nationwide cohort
Hilde T. van der Galien, P. Mutsaers, M. Jak, M. V. D. van der Poel +16 more
2025Blood1 citations Open access
Semantic Scholar
Whole Body CD8+ T Cell PET Imaging in Patients with DLBCL before and during Anti-CD19 CAR T Cell Therapy
J. V. van Doesum, K. Keijzer, J. D. de Boer, N. Smit +14 more
2024Blood1 citations
Semantic Scholar
Author Correction: Whole-body CD8+ T-cell PET imaging in patients with large B-cell lymphoma before and during CD19-directed CAR T-cell therapy: a phase 2 study
J. D. de Boer, K. Keijzer, J. V. van Doesum, N. Smit +15 more
2026Nature Communications0 citations Open access
Semantic Scholar
Risk of thrombosis and bleeding following CAR T‐cell therapy: Insights from the Dutch “Follow that CAR!” registry
A. K. Ko, P. Mutsaers, Lukas M. van Kleij, Amária Vledder +15 more
2026HemaSphere0 citations Open access
Semantic Scholar
1764 Decrease of metabolic active tumour volume of target- and unintentionally irradiated lesions after bridging radiotherapy prior to CAR T-cell therapy
M. Steen, K. Keijzer, Allard E. van Ark, L. V. van Dijk +6 more
2025Radiotherapy and Oncology0 citations
Semantic Scholar
Higher helios⁺ treg levels pre- and post-CAR T infusion are associated with inferior outcomes in patients with LBCL
Hilde T. van der Galien, N. Smit, Marije T. Nijk, Marieke Tienstra +8 more
2025Blood0 citations
Semantic Scholar
Population-Based External Validation of the CAR-Hematotox Score to Predict CAR T Cell Related Toxicity and Outcome in R/R LBCL Patients
J. D. de Boer, K. Keijzer, S. van Dorp, P. Mutsaers +19 more
2024Blood0 citations
Semantic Scholar
Reduction of Metabolic Active Tumor Volume Prior to CAR T-Cell Therapy Improves Survival Outcomes in Patients with Large B-Cell Lymphoma
K. Keijzer, J. D. de Boer, J. V. van Doesum, W. Noordzij +4 more
2023Blood0 citations
Semantic Scholar
MO-0960 Evaluating semi-automated 18F-FDG PET segmentation methods to predict Large B-cell lymphoma outcomes
K. Keijzer, T. V. van Meerten, J. D. de Boer, A. Niezink +1 more
2023Radiotherapy and Oncology0 citations
Semantic Scholar
P1462: POPULATION-BASED REAL WORLD RESULTS OF CD19-DIRECTED CAR T-CELL THERAPY FOR PATIENTS WITH RELAPSED OR REFRACTORY LARGE B-CELL LYMPHOMA: A DUTCH CAR T-CELL TUMORBOARD EXPERIENCE
A. Spanjaart, E. Pennings, P. Mutsaers, S. van Dorp +13 more
2022HemaSphere0 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

T. van Meerten×23
Invite
T. van Meerten — researcher profile on SciRah
J. V. van Doesum×19
Invite
J. V. van Doesum — researcher profile on SciRah
A. Niezink×17
Invite
A. Niezink — researcher profile on SciRah
K. Keijzer×14
Invite
K. Keijzer — researcher profile on SciRah

×11

Invite

L. V. van Dijk — researcher profile on SciRah

A. Spanjaart×9

Invite

A. Spanjaart — researcher profile on SciRah

Invite

M. Jak — researcher profile on SciRah

Invite

P. Mutsaers — researcher profile on SciRah

Invite

S. van Dorp — researcher profile on SciRah

M. V. D. van der Poel×9

Invite

M. V. D. van der Poel — researcher profile on SciRah

Invite

G. Huls — researcher profile on SciRah

Invite

W. Noordzij — researcher profile on SciRah